Dr. Craig Tanio is board certified physician in internal medicine and functional medicine. He is co-founder of Rezilir Health in Florida where he focuses on the application of precision medicine approaches to cognitive decline and complex chronic conditions.

 

His career has focused on helping improve the care of patients with complex chronic conditions. He has done this in multiple roles as a practicing physician, as Chief Medical Officer of a Medicare Advantage primary care led organization, as a partner in McKinsey and Company's Health Systems practice, as chief operating officer of a group of Federally Qualified Community Health Centers and as a former Chairman of the Maryland Health Care Commission. 

​

Since 2017, Dr. Tanio has collaborated with Dale Bredesen on the clinical implementation of precision medicine protocols for the prevention and reversal of cognitive decline. His work has focused on developing structured, reproducible care models designed to improve the execution of precision medicine in order to achieve significant and consistent outcomes. He has developed a framework to develop individualized intensive neuromodulatory protocols guided by frequent neurophysiologic assessment. The protocols incorporate modalities such as Hard Chamber Hyperbaric Oxygen Therapy following the Efrati Protocol, transcranial magnetic stimulation, class IV laser photobiomodulation, 19 channel neurofeedback, intravenous therapies, and select peptides through a compounding pharmacy.  He is collecting real world data on these approaches through an IRB sponsored registry. 

​

Craig is on faculty at the Johns Hopkins School of Medicine and the Institute for Neuro-Immune Medicine at Nova Southeastern. He received his medical degree from the University of California San Francisco, his MBA from the Wharton School and did his internal medicine training at the Hospital University of Pennsylvania where he was chief medical resident and a Robert Wood Johnson Foundation Clinical Scholar.